Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 10, 2021
AMRI has announced the appointment of Scott Waldman as senior vice president, corporate development.
read more
Monday, December 19, 2016
ERT, a l provider of high-quality patient data collection solutions for use in clinical drug development, has announced the acquisition of Exco InTouch, a provider of patient engagement, data capture and digital health solutions. The combined ...
read more
Thursday, August 17, 2017
ACF Bioservices announced the completion of construction on its dedicated cGMP-compliant 3400 square foot facility for gene and cell therapy product testing.
read more
Norwich focuses on manufacturing potent, solid dose products, including fast dissolve and controlled release tablets, while also providing a range of analytical services in-house.
read more
Tuesday, October 31, 2017
Sawai has entered into an exclusive agreement with AstraZeneca to manufacture and market Zomig Tablets Zomig Rapid Melt Tablets, a migraine medication in Japan.
read more
Wednesday, November 15, 2017
Arvinas has expanded its ongoing license agreement with Genentech for the development of new therapeutics using Arvinas' novel PROTAC technology.
read more
Thursday, December 21, 2017
MilliporeSigma has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, for its use in gene therapies.
read more
Penn Pharma, a leading global provider of integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry, today announced the completion of potent compound safety training and certification for ...
read more
Tuesday, October 06, 2015
Bristol-Myers Squibb has announced that the FDA has accepted for filing and review three supplemental New Drug Applications (sNDAs) for Daklinza(daclatasvir), an NS5A replication complex inhibitor, for use with sofosbuvir with or without ribavirin.
read more
Wednesday, March 27, 2019
Cambrex announced it will double the liquid packaging capacity and weekly output at its Mirabel, Québec site in Canada.
read more
Amneal Pharmaceuticals has announced a restructuring plan designed to reduce its cost base to and optimize its global manufacturing infrastructure.
read more
Tuesday, February 09, 2021
Catalent has signed an agreement to provide Decibel Therapeutics with process and analytical development, and CGMP clinical manufacturing services, for Decibel’s lead investigational gene therapy product candidate, DB-OTO.
read more
MPI Research, the largest single-site preclinical/early clinical contract research organization (CRO) globally, is pleased to announce a strategic partnership with inviCRO and 3D Imaging to unite world-class molecular imaging, radiochemistry, and ...
read more
Wednesday, March 07, 2018
Themis Bioscience and CEPI have announced a partnership under which Themis will provide advanced vaccine development and manufacturing for Lassa fever and MERS.
read more
Ortho Clinical Diagnostics announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
read more